Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles

Gene Therapy

Volumn 22, Issue 4, 2015, Pages 325-332

  Park, D H ^a   Jung, B K ^a   Lee, Y S ^a   Jang, J Y ^a   Kim, M K ^a   Lee, J K ^a   Park, H ^b   Seo, J ^c   Kim, C W ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Yonsei University Wonju   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENINE NUCLEOTIDE TRANSLOCASE 2; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; POLYETHYLENEIMINE; SHORT HAIRPIN RNA; SONOVUE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; EVALUATION STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROBUBBLE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RNA INTERFERENCE; SURVIVAL RATE; TUMOR REGRESSION; ULTRASOUND; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; DRUG EFFECTS; GENE TRANSFER; KIDNEY; LIVER; METABOLISM; TUMOR CELL LINE; ULTRASOUND THERAPY; XENOGRAFT;

MUS;

ADENINE NUCLEOTIDE TRANSLOCATOR 2; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; GENE TRANSFER TECHNIQUES; HETEROGRAFTS; KIDNEY; LIVER; MICE; MICROBUBBLES; NEOPLASM TRANSPLANTATION; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; ULTRASONIC THERAPY;

EID: 84926409743     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.120     Document Type: Article

References (50)

1. Lin C-R, Chen K-H, Yang C-H, Cheng J-T, Sheen-Chen S-M, Wu C-H et al. Sonoporation-mediated gene transfer into adult rat dorsal root ganglion cells. J Biomed Sci 2010; 17: 44.
2. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329-335.
3. Shen Z-Y, Hu B. Low-frequency low-intensity ultrasound with contrast agent for the treatment of subcutaneous tumors in mice. Sci Res Essays 2011; 6: 5579-5585.
4. Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi a novel tool for isoform-specific knock-down of VEGF and antiangiogenesis gene therapy of cancer. Biochem Biophys Res Commun 2003; 303: 1169-1178.
5. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Therapy 2005; 12: 461-466.
6. Jang J-Y, Choi Y, Jeon Y-K, Kim C-W. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res 2008; 10: R11.
7. Jang J-Y, Jeon Y-K, Kim C-W. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 2010; 10: 391.
8. Choi Y, Jeon YH, Jang J-Y, Chung J-K, Kim C-W. Treatment With mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination. Mol Ther 2011; 19: 979-989.
9. Jänicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009; 117: 219-221.
10. Doerner A, Pauschinger M, Badorff A, Noutsias M, Giessen S, Schulze K et al. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett 1997; 414: 258-262.
11. Luciakova K, Barath P, Poliakova D, Persson A, Nelson BD. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells the role of nuclear factor-1. J Biol Chem 2003; 278: 30624-30633.
12. Miller DL, Pislaru SV, Greenleaf JF. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somatic Cell Mol Genet 2002; 27: 115-134.
13. Thomas M, Klibanov A. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 2003; 62: 27-34.
14. Zhang Y, Satterlee A, Huang L. In vivo gene delivery by nonviral vectors: overcoming hurdles & quest. Mol Ther 2012; 20: 1298-1304.
15. Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Therapy 2000; 7: 31-34.
16. Aihara H, Miyazaki J-i. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
17. Yoshida A, Nagata T, Uchijima M, Higashi T, Koide Y. Advantage of gene gunmediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 2000; 18: 1725-1729.
18. Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923-936.
19. Newman C, Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Therapy 2007; 14: 465-475.
20. Erbacher P, Bettinger T, Belguise-Valladier P, Zou S, Coll JL, Behr JP et al. Transfection and physical properties of various saccharide, poly (ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1999; 1: 210-222.
21. Aoki K, Furuhata S, Hatanaka K, Maeda M, Remy J, Behr J et al. Polyethyleniminemediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Therapy 2001; 8: 504-514.
22. Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U et al. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Rel 2006; 112: 257-270.
23. Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasí F et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. J Control Rel 2001; 76: 169-181.
24. Saito M, Mazda O, Takahashi KA, Arai Y, Kishida T, Shin-Ya M et al. Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res 2007; 25: 1308-1316.
25. Xenariou S, Griesenbach U, Liang H, Zhu J, Farley R, Somerton L et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Therapy 2007; 14: 768-774.
26. Dang S-p, Wang R-x, Qin M-d, Zhang Y, Gu Y-z, Wang M-y et al. A novel transfection method for eukaryotic cells using polyethylenimine coated albumin microbubbles. Plasmid 2011; 66: 19-25.
27. Phillips LC, Klibanov AL, Wamhoff BR, Hossack JA. Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasoundmediated delivery. Ultrasound Med Biol 2010; 36: 1470-1480.
28. Liu J, Lewis TN, Prausnitz MR. Non-invasive assessment and control of ultrasoundmediated membrane permeabilization. Pharm Res 1998; 15: 918-924.
29. Wei W, Zheng-zhong B, Yong-jie W, Qing-wu Z, Ya-lin M. Bioeffects of lowfrequency ultrasonic gene delivery and safety on cell membrane permeability control. J Ultrasound Med 2004; 23: 1569-1582.
30. Zhou Y, Cui J, Deng CX. Dynamics of sonoporation correlated with acoustic cavitation activities. Biophys J 2008; 94: L51-L53.
31. Aigner A, Fischer D, Merdan T, Brus C, Kissel T, Czubayko F. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Therapy 2002; 9: 1700-1707.
32. Intra J, Salem AK. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Rel 2008; 130: 129-138.
33. Louis M, Dutoit S, Denoux Y, Erbacher P, Deslandes E, Behr J et al. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther 2006; 13: 367-374.
34. Dou S, Smith M, Wang Y, Rusckowski M, Liu G. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Cancer Biother Radiopharm 2013; 28: 335-342.
35. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
36. Demeneix B, Behr JP. Polyethylenimine (PEI). Adv Genet 2005; 53: 215-230.
37. Williams A. A possible alteration in the permeability of ascites cell membranes after exposure to acoustic microstreaming. J Cell Sci 1973; 12: 875-885.
38. Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008; 60: 1103-1116.
39. Okada K, Kudo N, Niwa K, Yamamoto K. A basic study on sonoporation with microbubbles exposed to pulsed ultrasound. J Med Ultrason 2005; 32: 3-11.
40. Forbes MM, Steinberg RL. Examination of inertial cavitation of Optison in producing sonoporation of Chinese hamster ovary cells. Ultrasound Med Biol 2008; 34: 2009-2018.
41. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Therapy 2002; 9: 1647-1652.
42. Herweijer H, Wolff J. Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453-458.
43. Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 2005; 30: 245-252.
44. Zhang L, Liu Y, Xiang G, Lv Q, Huang G, Yang Y et al. Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery. J Huazhong Univ Sci Technol [Medical Sciences] 2011; 31: 39-45.
45. Shen Z, Brayman A, Chen L, Miao C. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Therapy 2008; 15: 1147-1155.
46. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 415-447.
47. Song S, Shen Z, Chen L, Brayman A, Miao C. Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver. Gene Therapy 2011; 18: 1006-1014.
48. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/γ mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182.
49. Leighton T. The Acoustic Bubble. Academic Press: New York, NY, USA, 1994.
50. Schneider M. Characteristics of SonoVue™. Echocardiography 1999; 16: 743-746.